BlueCrest Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-10,714
Closed -$330K 1850
2018
Q1
$330K Buy
+10,714
New +$330K 0.01% 968